About Careers Internship MedBlog Contact us
Medindia LOGIN REGISTER
Advertisement

Party Drug Ketamine Offers Rapid Relief From Chronic Depression

by VR Sreeraman on October 6, 2012 at 4:55 PM
Font : A-A+

 Party Drug Ketamine Offers Rapid Relief From Chronic Depression

Researchers have found a clue on how small amount of the drug ketamine offers immediate relief for patients who are chronically depressed and for those who are resistant to treatments.

The ability of the drug was first observed at Yale University.

Advertisement

A review of scientific research written by Yale School of Medicine researchers has provided evidence suggesting that the pediatric anesthetic helps regenerate synaptic connections between brain cells damaged by stress and depression.

Ketamine works on an entirely different type of neurotransmitter system than current antidepressants, which can take months to improve symptoms of depression and do not work at all for one out of every three patients.
Advertisement

Understanding how ketamine works in the brain could lead to the development of an entirely new class of antidepressants, offering relief for tens of millions of people suffering from chronic depression.

"The rapid therapeutic response of ketamine in treatment-resistant patients is the biggest breakthrough in depression research in a half century," said Ronald Duman, Elizabeth Mears and House Jameson Professor of Psychiatry and Professor of Neurobiology.

Duman and George K. Aghajanian, also professor of psychiatry at Yale, are co-authors of the review.

Understanding how ketamine works is crucial because of the drug's limitations. The improvement in symptoms, which are evident just hours after ketamine is administered, lasts only a week to 10 days. In large doses, ketamine can cause short-term symptoms of psychosis and is abused as the party drug "Special K."

In their research, Duman and others show that in a series of steps ketamine triggers release of neurotransmitter glutamate, which in turn stimulates growth of synapses. Research at Yale has shown that damage of these synaptic connections caused by chronic stress is rapidly reversed by a single dose of ketamine.

The original link between ketamine and relief of depression was made at the Connecticut Mental Health Center in New Haven by John Krystal, chair of the department of psychiatry at Yale, and Dennis Charney, now dean of Mt. Sinai School of Medicine, who helped launch clinical trials of ketamine while at the National Institute of Mental Health.

Efforts to develop drugs that replicate the effects of ketamine have produced some promising results, but they do not act as quickly as ketamine. Researchers are investigating alternatives they hope can duplicate the efficacy and rapid response of ketamine.

The review was published in the latest issue of the journal Science.

Source: ANI
Advertisement

Advertisement
News A-Z
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
What's New on Medindia
Test Your Knowledge on Liver Transplantation
Organ Donation Week 2022 - 'Take the Pledge to Save Lives'
Test your Knowledge on Heart Transplantation
View all
Recommended Reading
News Archive
Date
Category
Advertisement
News Category

Medindia Newsletters Subscribe to our Free Newsletters!
Terms & Conditions and Privacy Policy.

More News on:
Adolescence Depression Drug Toxicity Depression Signature Drug Toxicity Stress Relief Through Alternative Medicine Andropause / Male Menopause Pregnancy and Complications Holistic Management for Depression Tourette Syndrome Dealing with Menopause symptoms through lifestyle changes 

Most Popular on Medindia

Blood Donation - Recipients Indian Medical Journals The Essence of Yoga Color Blindness Calculator Drug Interaction Checker Noscaphene (Noscapine) How to Reduce School Bag Weight - Simple Tips Daily Calorie Requirements Nutam (400mg) (Piracetam) Accident and Trauma Care
This site uses cookies to deliver our services. By using our site, you acknowledge that you have read and understand our Cookie Policy, Privacy Policy, and our Terms of Use